Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,006 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Delanzomib (CEP-18770) in Combination With Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

NCT01348919

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Teva Investigational Site 1 Augusta, Georgia, United States
  • Teva Investigational Site 3 Lexington, Kentucky, United States
  • Teva Investigational Site 2 Houston, Texas, United States
  • Teva Investigational Site 201 Auckland, New Zealand
View Trial Details
Completed

Study to Assess the Efficacy and Safety of Umbralisib in Participants With Non-Follicular Indolent Non-Hodgkin's Lymphoma

NCT03364231

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
Locations
  • TG Therapeutics Investigational Trial Site Washington D.C., District of Columbia, United States
  • TG Therapeutics Investigational Trial Site Boston, Massachusetts, United States
  • TG Therapeutics Investigational Trial Site Hackensack, New Jersey, United States
  • TG Therapeutics Investigational Trial Site New York, United States
View Trial Details
Completed

Vaccination With Dendritic Cell/Tumor Fusions With Autologous Stem Cell Transplants in Patients With Multiple Myeloma

NCT00458653

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute/Brigham & Women's Hospital Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Rambam Medical Center Haifa, Israel
View Trial Details
Completed

CART-19 for Multiple Myeloma

NCT02135406

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

NCT00014508

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Cancer Center at Tufts - New England Medical Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis

NCT00003353

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • Sylvester Cancer Center, University of Miami Miami, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • CCOP - Evanston Evanston, Illinois, United States
View all 17 locations
View Trial Details
Completed

Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma

NCT00003615

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +27 more
Locations
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • CCOP - Southern Nevada Cancer Research Foundation Las Vegas, Nevada, United States
  • Trinitas Hospital - Jersey Street Campus Elizabeth, New Jersey, United States
View Trial Details
Completed

VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma

NCT04151615

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Soonchunhyang University Bucheon hospital Bucheon-si, South Korea
  • Inje university Haeundae Paik Hospital Busan, South Korea
  • Kosin University Gospel hospital Busan, South Korea
  • Pusan national University Hospital Busan, South Korea
View all 24 locations
View Trial Details

Related conditions